Americans have more trust in science than most of the rest of the world, according to a new survey of people in 140 countries, a finding that may seem difficult to explain in a country deeply divided by issues such as the benefits and harms of vaccines. According to the newest edition of the Wellcome … [Read more…]
Ovulation. Endometriosis. And especially: menopause. These once taboo words — among others — have become part of our daily vocabulary and conversations, a sign of greater interest in, and knowledge of, women’s health. Yet even as women’s health has been receiving more attention than perhaps ever before, women remain poorly represented in clinical trials, and … [Read more…]
Below is a lightly edited, AI-generated transcript of the “First Opinion Podcast” interview with Morgan McSweeney. Be sure to sign up for the weekly “First Opinion Podcast” on Apple Podcasts, Spotify, or wherever you get your podcasts. Get alerts about each new episode by signing up for the “First Opinion Podcast” newsletter. And don’t forget to sign … [Read more…]
The number of basic science papers published by recipients of National Institutes of Health grants has been falling since 2013, the year the agency’s budget was cut by 5%, according to a new analysis. President Trump’s budget proposal to slash NIH funding by nearly 40% would further erode basic biomedical research, warns the author, a … [Read more…]
On May 23, the Trump administration issued an executive order titled “Restoring Gold Standard Science.” Using agreeable rhetoric, the order says that it aims to safeguard scientific rigor, prevent misconduct, and restore public trust in government science. But beneath this golden gloss lies a return to strategies that threaten to weaken federal science, dismiss scientific … [Read more…]
In the world of modern healthcare, the potential of gene editing is still largely unrealized. This medical revolution allows scientists to change the structure of DNA for a world of endless possibilities, from helping treat previously incurable diseases to producing replacements for damaged tissues and organs. CRISPR QC, a San Diego-based biotechnology company, is working … [Read more…]